Not yet recruiting
Effectiveness of a Visual Telerehabilitation Program on Visual Perception in Children, Adolescents and Young Adults With Hemianopsia Consecutive to a Brain Tumour
NCT07558395· Institut National de la Santé Et de la Recherche Médicale, France· Source
Contact: Darren Pr Hargrave
Recruiting
A Phase I/II Trial of JR-446 in Mucopolysaccharidosis Type IIIB (MPS IIIB)
NCT07640984· Phase 1/2· JCR Pharmaceuticals Co., Ltd.· Source
Contact: James Davison
Not yet recruiting
Long-Term Extension Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon Skipping to Evaluate the Safety and Efficacy of Endosomal Escape Vehicle Phosphorodiamidate Morpholino Oligomer Platform Products (ELEVATE-LTE)
NCT07682129· Phase 2· Entrada Therapeutics, Inc.· Source
Recruiting
A Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
NCT05199688· Phase 3· Hoffmann-La Roche· Source
Recruiting
OLE Study With Filgotinib in JIA
NCT07553182· Phase 3· Alfasigma S.p.A.· Source
Contact: Sandrine Lacassagne, Dr.
Not yet recruiting
Advanced MRI in IVH
NCT07412886· Great Ormond Street Hospital for Children NHS Foundation Trust· Source
Contact: Kristian Aquilina
Recruiting
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
NCT07287982· Phase 2· argenx· Source
Contact: Mariacristina Scoto
Enrolling by invitation
A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)
NCT07156578· Phase 2· Rhythm Pharmaceuticals, Inc.· Source
Recruiting
Thalamic Recordings in Children Undergoing SEEG
NCT06453759· Great Ormond Street Hospital for Children NHS Foundation Trust· Source
Contact: Aswin Chari, PhD
Recruiting
A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45
NCT07038824· Phase 1/2· Entrada Therapeutics, Inc.· Source
Contact: Giovanni Baranello
Recruiting
A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44
NCT07037862· Phase 1/2· Entrada Therapeutics, Inc.· Source
Contact: Mariacristina Scoto
Active, not recruiting
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
NCT06872125· Phase 3· Stoke Therapeutics, Inc· Source
Not yet recruiting
The FLaME Cognitive Rehabilitation Study for Childhood Brain Tumour
NCT06770335· Great Ormond Street Hospital for Children NHS Foundation Trust· Source
Contact: Charlotte P Malcolm, DClinPsy
Active, not recruiting
Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis Participants 12 Months of Age and Older
NCT06460506· Phase 3· Vertex Pharmaceuticals Incorporated· Source
Active, not recruiting
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy
NCT05861999· Phase 4· Hoffmann-La Roche· Source
Active, not recruiting
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy
NCT05861986· Phase 4· Hoffmann-La Roche· Source
Active, not recruiting
A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).
NCT06412666· Phase 2/3· Cytokinetics· Source
Active, not recruiting
A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD)
NCT06128564· Phase 2· Hoffmann-La Roche· Source
Enrolling by invitation
Evaluation of Long-Term Safety and Efficacy of Vanzacaftor/Tezacaftor/Deutivacaftor in Cystic Fibrosis Participants 1 Year of Age and Older
NCT05844449· Phase 3· Vertex Pharmaceuticals Incorporated· Source
Active, not recruiting
Base Edited CAR T Cells Against AML: Deep Conditioning Ahead of Allogeneic Stem Cell Transplantation
NCT05942599· Phase 1· Great Ormond Street Hospital for Children NHS Foundation Trust· Source
Active, not recruiting
Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab
NCT05626855· Phase 3· Scholar Rock, Inc.· Source
Active, not recruiting
A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II)
NCT05371613· Phase 2/3· Denali Therapeutics Inc.· Source
Active, not recruiting
Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age
NCT05422222· Phase 3· Vertex Pharmaceuticals Incorporated· Source
Recruiting
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
NCT05039619· Phase 2· Hoffmann-La Roche· Source
Active, not recruiting
Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)
NCT05356195· Phase 3· Vertex Pharmaceuticals Incorporated· Source
Active, not recruiting
A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors
NCT05135559· Phase 3· Novo Nordisk A/S· Source
Recruiting
A Clinical Study to Assess Safety, Efficacy and Pharmacodynamic Profile of GNT0004 in Duchenne Muscular Dystrophy
NCT07856329· Phase 2/3· Genethon· Source
Contact: Medical Lead
Enrolling by invitation
A Long-term Follow-up Study in Participants Who Received CTX001
NCT04208529· Phase 3· Vertex Pharmaceuticals Incorporated· Source
Recruiting
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
NCT04625907· Phase 1/2· University of Birmingham· Source
Contact: Olga Slater
Active, not recruiting
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibitors
NCT04083781· Phase 3· Novo Nordisk A/S· Source
Recruiting
Simple Bone Cysts in Kids
NCT02193841· Phase 3· The Hospital for Sick Children· Source
Contact: Kim Gardiner
Active, not recruiting
Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy
NCT00683319· Children's Cancer and Leukaemia Group· Source